171 likes | 364 Views
Interaction of LSPR with thrombin as an Inhibitor of Blood Clotting. Brandon T. Brown and Toni A. Trumbo Department of Chemistry and Biochemistry, Bloomsburg University of P ennsylvania, Bloomsburg PA 17815. Blood Clotting. Thrombin Catalytic Site. Vitamin K Antagonists.
E N D
Interaction of LSPR with thrombin as an Inhibitor of Blood Clotting Brandon T. Brown and Toni A. Trumbo Department of Chemistry and Biochemistry, Bloomsburg University of Pennsylvania, Bloomsburg PA 17815
Vitamin K Antagonists • Warfarin= most commonly used • “Gold Standard” • Oral available • One dose daily • Short comings • Self-testing • Risk of hemorrhage • Interactions
Direct Thrombin Inhibitors • Dabigatran • Oral available • Less testing • Fewer life-threatening bleeds • Two doses daily • Risks • Harder to reverse or completely irreversible
LSPR • Inhibit thrombin directly • Reversible • Orally available
Clot Assay • 5 µM Fibrinogen was added to Assay buffer • Equilibrated to Room Temperature for 5 minutes • 2.2 nM Thrombin was added, the solution mixed • The solution was inserted into the instrument which then measured the absorbance • 7200 sec • 325 nm
Representative Uninhibited spectrum Hill Equation F=(a(x^b))/((c^b)+(x^b))
Average spectrum and error bars 5 µM LSPR
Conclusion • LSPR does inhibit clot formation • Maximal inhibition found
Future work • HPLC • Minimum dosage
Acknowledgements • Elizabeth Ola • Jackie North • Department of Chemistry and Biochemistry